Reubi JC - Search Results

1

Three-year recurrence-free survival in a patient with recurrent medulloblastoma after resection, high-dose chemotherapy, and intrathecal Yttrium-90-labeled DOTA0-D-Phe1-Tyr3-octreotide radiopeptide brachytherapy.

Beutler D, Avoledo P, Reubi JC, Mäcke HR, Müller-Brand J, Merlo A, Kühne T. Beutler D, et al. Among authors: reubi jc. Cancer. 2005 Feb 15;103(4):869-73. doi: 10.1002/cncr.20822. Cancer. 2005. PMID: 15641034 Free article.

2

Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas.

Merlo A, Hausmann O, Wasner M, Steiner P, Otte A, Jermann E, Freitag P, Reubi JC, Müller-Brand J, Gratzl O, Mäcke HR. Merlo A, et al. Among authors: reubi jc. Clin Cancer Res. 1999 May;5(5):1025-33. Clin Cancer Res. 1999. PMID: 10353735 Clinical Trial.

3

Successful diffusible brachytherapy (dBT) of a progressive low-grade astrocytoma using the locally injected peptidic vector and somatostatin analogue [90Y]-DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC).

Hofer S, Eichhorn K, Freitag P, Reubi JC, Muller-Brand J, Maecke H, Merlo A. Hofer S, et al. Among authors: reubi jc. Swiss Med Wkly. 2001 Nov 10;131(43-44):640-4. doi: 10.4414/smw.2001.09822. Swiss Med Wkly. 2001. PMID: 11835112 Free article.

4

Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p.

Kneifel S, Cordier D, Good S, Ionescu MC, Ghaffari A, Hofer S, Kretzschmar M, Tolnay M, Apostolidis C, Waser B, Arnold M, Mueller-Brand J, Maecke HR, Reubi JC, Merlo A. Kneifel S, et al. Among authors: reubi jc. Clin Cancer Res. 2006 Jun 15;12(12):3843-50. doi: 10.1158/1078-0432.CCR-05-2820. Clin Cancer Res. 2006. PMID: 16778112

5

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.

Wild D, Schmitt JS, Ginj M, Mäcke HR, Bernard BF, Krenning E, De Jong M, Wenger S, Reubi JC. Wild D, et al. Among authors: reubi jc. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1338-47. doi: 10.1007/s00259-003-1255-5. Epub 2003 Aug 21. Eur J Nucl Med Mol Imaging. 2003. PMID: 12937948

6

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.

Wicki A, Wild D, Storch D, Seemayer C, Gotthardt M, Behe M, Kneifel S, Mihatsch MJ, Reubi JC, Mäcke HR, Christofori G. Wicki A, et al. Among authors: reubi jc. Clin Cancer Res. 2007 Jun 15;13(12):3696-705. doi: 10.1158/1078-0432.CCR-06-2965. Clin Cancer Res. 2007. PMID: 17575235

7

Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial.

Cordier D, Forrer F, Bruchertseifer F, Morgenstern A, Apostolidis C, Good S, Müller-Brand J, Mäcke H, Reubi JC, Merlo A. Cordier D, et al. Among authors: reubi jc. Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1335-44. doi: 10.1007/s00259-010-1385-5. Epub 2010 Feb 16. Eur J Nucl Med Mol Imaging. 2010. PMID: 20157707 Free article. Clinical Trial.

8

NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors.

Eisenwiener KP, Prata MI, Buschmann I, Zhang HW, Santos AC, Wenger S, Reubi JC, Mäcke HR. Eisenwiener KP, et al. Among authors: reubi jc. Bioconjug Chem. 2002 May-Jun;13(3):530-41. doi: 10.1021/bc010074f. Bioconjug Chem. 2002. PMID: 12009943 Free article.

9

68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.

Wild D, Mäcke HR, Waser B, Reubi JC, Ginj M, Rasch H, Müller-Brand J, Hofmann M. Wild D, et al. Among authors: reubi jc. Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):724. doi: 10.1007/s00259-004-1697-4. Eur J Nucl Med Mol Imaging. 2005. PMID: 15551131 No abstract available.

10

Candidates for peptide receptor radiotherapy today and in the future.

Reubi JC, Mäcke HR, Krenning EP. Reubi JC, et al. J Nucl Med. 2005 Jan;46 Suppl 1:67S-75S. J Nucl Med. 2005. PMID: 15653654 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters